ApoVax104-TB

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameApoVax104-TB

Drug Alias Nametuberculosis vaccine (ApoVax)tuberculosis vaccine (ApoImmune)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionCluster of differentiation 8 stimulantsTumor necrosis factor receptor superfamily member 9 modulatorsT-cell surface antigen CD4 agonists

TargetsT-cell surface antigen CD4Cluster of differentiation 8Tumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesApoVax Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesApoVax Inc

Active IndicationsN/A

Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A